Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 23 November, 2009 and appeared in  Issue 497Blood Glucose Control

Scientists Find Link between Insulin and Core Body Temperature

A team led by scientists at The Scripps Research Institute have discovered a direct link between insulin -- a hormone long associated with metabolism and metabolic disorders such as diabetes -- and core body temperature.

Advertisement

While much research has been conducted on insulin since its discovery in the 1920's, this is the first time the hormone has been connected to the fundamental process of temperature regulation.

The scientists found that when insulin was injected directly into a specific area of the brain in rodents, core body temperature rose, metabolism increased, and brown adipose (fat) tissue was activated to release heat. The research team also found that these effects were dose-dependent -- up to a point, the more insulin, the more these metabolic measures rose.

"Scientists have known for many years that insulin is involved in glucose regulation in tissues outside the brain," said Scripps Research neurobiologist Manuel Sanchez-Alavez, first author of the new paper. "The connection to temperature regulation in the brain is new."

In addition to suggesting a fresh perspective on diseases such as diabetes that involve the disruption of insulin pathways, the study adds to our understanding of core body temperature -- the temperature of those parts of the body containing vital organs, namely the trunk and the head. Normally, core body temperature stays within a narrow range so that key enzymatic reactions can occur. When core body temperature goes outside this range for prolonged periods -- higher as in fever, or lower as in hypothermia -- the result is harm to the body.

More modest variations in core body temperature are associated with our daily 24-hour sleep-wake cycle, the female monthly hormonal cycle, and, intriguingly, the effects of severe calorie restriction.

"Our paper highlights the possibility that differences in core temperature may play a role in obesity and may represent a therapeutic area in future drug design," added Osborn.

The scientists suspected that insulin in the brain might work to warm the body through a specific pathway involving signals that traveled from the brain's preoptic area, down the spinal cord, to neurons that direct brown adipose tissue to expend energy to produce heat.

Brown adipose tissue, also known as brown fat, is distinct from white fat in that it burns calories rather than storing them. While in years past, brown fat was thought to exist in humans only when they are infants, recent studies have shown that brown fat deposits are also found in healthy adults, especially around their collarbones and necks. Interestingly, older people have less brown fat than younger people, and obese individuals have less than lean individuals.

Specifically, the scientists examined the effect of insulin injections in the preoptic area of rats on brown adipose tissue using computerized tomography (CT) scans and positron emission tomography (PET) scans. Rodents possess brown adipose tissue in two large masses on their backs between the shoulder blades.

When the activity of the brown fat was captured visually, the data confirmed the scientists' projections.

Studies went forward examining the effects of insulin on metabolism, specifically by measuring the effect of insulin injections in the preoptic area of mice on oxygen consumption and carbon dioxide production. Again, results showed that metabolic rate increased with an increase in insulin.

All the techniques -- PET/CT scan, metabolic studies, telemetric work -- support the hyperthermic effect of insulin in rodent models.

The authors note that while their new paper illuminates a key piece of the puzzle of the body's metabolic processes, it also raises many intriguing questions: how does insulin get to the brain's preoptic area -- does it cross the blood-brain barrier or is it produced locally? Are diabetics, who are insensitive to insulin in peripheral tissues, still sensitive to insulin in the brain; if so, could this dichotomy be used in the development of a new therapy? Could scientists find a way to use these new insights to increase energy expenditure for the purpose of weight loss?

The paper was published recently in an advance, online issue of the journal Diabetes, a journal of the American Diabetes Association, and will appear in the January print edition of the publication. Insulin causes hyperthermia by direct inhibition of warm sensitive neurons

 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 23 November, 2009 and appeared in  Issue 497Blood Glucose Control

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

2012 Most Popular Articles:

ADA/EASD Issue New Hyperglycemia Management Guidelines
Posted April 26, 2012
Type 2 More Dangerous in Children
Posted May 03, 2012
It’s the Variety of Fruit-and-Veggie That Lower Diabetes Risk
Posted May 03, 2012
Questioning Carbohydrate Restriction in Diabetes Management
Posted May 18, 2012
Ultra-Long-Acting Insulin Degludec, Two New Studies
Posted April 26, 2012
Eating Low Glycemic Index Foods at Breakfast Can Control Blood Sugar throughout the Day
Posted April 18, 2012
Metformin May Treat a Leading Cause of Blindness
Posted May 10, 2012
A Candy Treatment that Fights Diabetes and May Replace TZD's?
Posted May 10, 2012
Metformin May Not Be the Golden Pill After All for Treating Type 2 Diabetes
Posted April 18, 2012
Doubts Over Long Term Effectiveness of Group Education for Diabetes Patients
Posted May 03, 2012

See more most popular…


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Marilyn Porter, RD, CDE | Melissa Diane Smith | Paul Chous, M.A., OD | Philip A. Wood PhD | Sheri R. Colberg PhD | Sherri Shafer | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |
 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control
Announcement:



Search Articles On Diabetes In Control